The Latest Cardiac and Vascular News
Virtual-First Cardiology Company, Heartbeat Health, Achieves SOC 2® Security Control Compliance Certification, Reinforcing Its Commitment to Healthcare Data Security & Privacy. NEW YORK, March 07, 2022 (GLOBE NEWSWIRE) — Heartbeat Health, a Virtual-First Cardiology company that leverages data, device connectivity, and clinicians to deliver on-demand cardiovascular services, announced today that […]
VILLEPINTE, France, March 7, 2022 /PRNewswire/ — Guerbet (FR0000032526 GBT), a global leader in medical imaging, announces it will more than double its line of microcatheters and launch a new line of guidewires, resulting in a broad range of interventional imaging and embolization solutions available. The company obtained its original offering of 18 references of SeQure® […]
– Reports Promising Early Data from Lead Clinical Program, JK07, for the Treatment of Heart Failure with Reduced Ejection Fraction – – Initiates Enrollment in Second Cohort of JK07 Phase 1 Dose Escalation Study – GAITHERSBURG, Md.–(BUSINESS WIRE)–Salubris Biotherapeutics, Inc. (SalubrisBio), a clinical-stage biotechnology company dedicated to discovering and developing novel […]
– The breakthrough approval expands the existing indication of Jardiance® to include adults with heart failure with preserved ejection fraction (HFpEF), an underserved patient population that previously had no approved therapies in Europe – European marketing authorization follows the U.S. Food and Drug Administration (FDA)’s approval received on 24 February 2022 […]
This week on Investor Insights, host Ken Dropiewski interviews James Eadie, Managing Director of Santé Ventures. They discuss a number of topics including James’s journey into Santé Ventures, Santé’s portfolio, and the working relationship between Santé and early stage companies.
ST. PAUL, Minn.–(BUSINESS WIRE)–Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for peripheral and coronary vascular disease, today announced that it has appointed Jeffery W. Chambers, M.D., as Chief Medical Officer. “CSI is developing an exciting product pipeline that targets some […]
The world’s first cellular-connected pulse oximeter facilitates remote monitoring for 67 million patients with chronic diseases. TAMPA, Fla., March 3, 2022 /PRNewswire/ — Smart Meter, the leader in cellular-enabled remote patient monitoring (RPM) data and devices, announces the release of the iPulseOxTM, the world’s first cellular-connected pulse oximeter, furthering the transformation of remote […]
SILVER SPRING, Md., March 03, 2022 (GLOBE NEWSWIRE) — Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, today reported financial results for the fourth quarter and full year ended December 31, 2021. […]
MARCH 3, 2022 San Antonio, TX – Privately held Bluegrass Vascular Technologies, a leading innovator and global manufacturer of lifesaving devices and methods based on the Inside-Out® vascular access procedure, today announced the closing of a $5.0 million financing in convertible promissory notes to a group of qualified investors, including new […]
S-CATH™ M is the only rapid-response, high-density esophageal temperature probe that is visible on 3D cardiac mapping systems. ENGLEWOOD, Colo., March 3, 2022 /PRNewswire/ — CIRCA Scientific, Inc. announced today that its S-CATH™ M Esophageal Temperature Probe is now cleared for sale in the United States. The new S-CATH M Probe can be […]
